Casper C, Corey L, Cohen J, Damania B, Gershon A, Kaslow D
NPJ Vaccines. 2022; 7(1):108.
PMID: 36127367
PMC: 9488886.
DOI: 10.1038/s41541-022-00535-4.
Idam Mamimandjiami A, Mouinga-Ondeme A, Ramassamy J, Djuicy D, Afonso P, Mahe A
Viruses. 2021; 13(2).
PMID: 33503816
PMC: 7911267.
DOI: 10.3390/v13020175.
Cesarman E, Damania B, Krown S, Martin J, Bower M, Whitby D
Nat Rev Dis Primers. 2019; 5(1):9.
PMID: 30705286
PMC: 6685213.
DOI: 10.1038/s41572-019-0060-9.
Etta E, Alayande D, Mavhandu-Ramarumo L, Gachara G, Bessong P
Viruses. 2018; 10(9).
PMID: 30150604
PMC: 6164965.
DOI: 10.3390/v10090458.
Betsem E, Cassar O, Afonso P, Fontanet A, Froment A, Gessain A
PLoS Negl Trop Dis. 2014; 8(5):e2851.
PMID: 24831295
PMC: 4022623.
DOI: 10.1371/journal.pntd.0002851.
A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.
Dow D, Cunningham C, Buchanan A
J Pediatric Infect Dis Soc. 2014; 3(1):66-76.
PMID: 24567845
PMC: 3933043.
DOI: 10.1093/jpids/pit051.
Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among Ugandans.
Shebl F, Emmanuel B, Bunts L, Biryahwaho B, Kiruthu C, Huang M
J Med Virol. 2013; 85(9):1602-10.
PMID: 23852686
PMC: 3755768.
DOI: 10.1002/jmv.23613.
Kaposi sarcoma presenting as dermal nodule.
Alam K, Maheshwari V, Varshney M, Aziz M, Shahid M, Basha M
BMJ Case Rep. 2012; 2011.
PMID: 22696625
PMC: 3082061.
DOI: 10.1136/bcr.01.2011.3789.
Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region.
de Souza V, Sumita L, Nascimento M, Oliveira J, Mascheretti M, Quiroga M
J Infect Dis. 2007; 196(6):844-52.
PMID: 17703414
PMC: 3543984.
DOI: 10.1086/520549.
Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.
Taylor M, Chohan B, Lavreys L, Hassan W, Huang M, Corey L
J Infect Dis. 2004; 190(3):484-8.
PMID: 15243920
PMC: 6768555.
DOI: 10.1086/421466.
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.
Dourmishev L, Dourmishev A, Palmeri D, Schwartz R, Lukac D
Microbiol Mol Biol Rev. 2003; 67(2):175-212, table of contents.
PMID: 12794189
PMC: 156467.
DOI: 10.1128/MMBR.67.2.175-212.2003.
Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma.
Dedicoat M, Newton R
Br J Cancer. 2003; 88(1):1-3.
PMID: 12556950
PMC: 2376771.
DOI: 10.1038/sj.bjc.6600745.
Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.
Ablashi D, Chatlynne L, Whitman Jr J, Cesarman E
Clin Microbiol Rev. 2002; 15(3):439-64.
PMID: 12097251
PMC: 118087.
DOI: 10.1128/CMR.15.3.439-464.2002.
A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.
Serraino D, Toma L, Andreoni M, Butto S, Tchangmena O, Sarmati L
Eur J Epidemiol. 2002; 17(9):871-6.
PMID: 12081107
DOI: 10.1023/a:1015678312153.
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.
Barillari G, Ensoli B
Clin Microbiol Rev. 2002; 15(2):310-26.
PMID: 11932235
PMC: 118071.
DOI: 10.1128/CMR.15.2.310-326.2002.
Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.
Boshoff C, Weiss R
Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):517-34.
PMID: 11313009
PMC: 1088442.
DOI: 10.1098/rstb.2000.0778.
